NGL Fine-Chem Limited (BOM:524774)
2,229.75
-25.30 (-1.12%)
At close: Apr 17, 2026
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 14.38 billion as of April 20, 2026. Its market cap has increased by 103.85% in one year.
Market Cap
14.38B
Enterprise Value
14.71B
Revenue
4.47B
Ranking
n/a
PE Ratio
40.66
Stock Price
2,229.75
Market Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 14.38B, an increase of 17,788.22%. That is a compound annual growth rate of 27.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 13.78B | 58.25% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shilpa Medicare | 80.33B |
| Suven Life Sciences | 55.59B |
| Gujarat Themis Biosyn | 36.41B |
| IOL Chemicals and Pharmaceuticals | 26.76B |
| Sai Parenteral's | 21.63B |
| Bajaj HealthCare | 10.54B |
| Anlon Healthcare | 7.54B |
| Shree Ganesh Remedies | 6.83B |